Status:
COMPLETED
Whey Protein Study - Identification of Sustainable Satiety
Lead Sponsor:
University of Aberdeen
Conditions:
Satiety
Eligibility:
MALE
20-75 years
Phase:
NA
Brief Summary
This study will have the primary aim to investigate within-day changes in appetite after consumption of high-protein (HP, 30% of calories) and normal, or low, protein (LP, 15% of calories) whey protei...
Detailed Description
A randomized crossover design in 10 overweight/obese (BMI 26-40) men and 10 lean men (BMI 18.5-25). The control will be water. Each subject will attend the HNU on six separate occasions. The five test...
Eligibility Criteria
Inclusion
- BMI = 18.5-40kg/m2
Exclusion
- Diabetes
- Severe gastrointestinal disorders
- Kidney disease
- Thromboembolic or coagulation disease
- Hepatic disease
- Alcohol or any other substance abuse
- Gout
- Eating disorders
- Food allergy
- Unregulated thyroid disease
- Psychiatric disorders (including severe depression, lithium treatment, schizophrenia, severe behavioural disorders)
- Vegetarians \& Vegans
- Medication
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT02246543
Start Date
August 1 2013
End Date
October 1 2015
Last Update
March 24 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rowett Institute of Nutrition & Health, University of Aberdeen
Aberdeen, Aberdeen City, United Kingdom, AB21 9SB